marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 10-30-2024
Summit Therapeutics Cash Flow 2011-2024 | SMMT
Annual Cash Flow Summit Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-76.8 M | -41.6 M | -72.6 M | -48.1 M | -20.8 M | -21.5 M | - | - | - | - | - | - | - |
Depreciation & Amortization |
198 K | 349 K | 330 K | 302 K | 321 K | 198 K | - | - | - | - | - | - | - |
Accounts Payables |
2.67 M | 355 K | 4.37 M | 6.14 M | 4.47 M | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | 349 K | 1.46 M | 331 K | 541 K | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Summit Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -30.1 M | - | - | - | -13.1 M | - | -46.8 M | -38.2 M | -19 M | - | -63.4 M | -39.8 M | -20.7 M | - | -40.1 M | -23.5 M | -4.96 M | - | -13.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | 27 K | - | - | - | 90 K | - | 217 K | 232 K | 69 K | - | 251 K | 170 K | 80 K | - | 267 K | 175 K | 72 K | - | 268 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
3.25 M | 3.34 M | 6.37 M | 2.67 M | 3.31 M | 987 K | 710 K | 355 K | 1.43 M | 3.57 M | 6.96 M | 4.37 M | 5.88 M | 6.95 M | 4.11 M | 6.14 M | 6.14 M | 6.14 M | 6.14 M | 4.47 M | 4.47 M | - | - | 6.26 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | 349 K | 140 K | 238 K | 870 K | 1.46 M | 2.29 M | 1.05 M | 447 K | 331 K | 331 K | 331 K | 331 K | 541 K | 541 K | - | - | 3.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency